LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

Search

STAAR Surgical Co

Chiusa

SettoreSettore sanitario

27.15 0.37

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

27.07

Massimo

27.3

Metriche Chiave

By Trading Economics

Entrata

37M

-17M

Vendite

1.7M

44M

P/E

Media del settore

55.443

35.293

Margine di Profitto

-37.933

Dipendenti

1,157

EBITDA

48M

-23M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-3.06% downside

Dividendi

By Dow Jones

Utili prossimi

29 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

455M

1.4B

Apertura precedente

26.78

Chiusura precedente

27.15

Notizie sul Sentiment di mercato

By Acuity

100%

0%

353 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

STAAR Surgical Co Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 set 2025, 23:07 UTC

Acquisizioni, Fusioni, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

5 ago 2025, 10:10 UTC

Acquisizioni, Fusioni, Takeovers

Alcon to Buy Staar Surgical for $1.5 Billion

16 set 2025, 13:12 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16 set 2025, 13:12 UTC

Acquisizioni, Fusioni, Takeovers

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16 set 2025, 13:11 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16 set 2025, 13:10 UTC

Acquisizioni, Fusioni, Takeovers

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

8 ago 2025, 13:40 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 ago 2025, 05:01 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

Confronto tra pari

Modifica del prezzo

STAAR Surgical Co Previsione

Obiettivo di Prezzo

By TipRanks

-3.06% in calo

Previsioni per 12 mesi

Media 26.33 USD  -3.06%

Alto 28 USD

Basso 18 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per STAAR Surgical Co - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

8 ratings

0

Acquista

8

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

18.604 / 20.07Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Very Strong Bullish Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

353 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat